Cargando…
Permanent Pacemaker Placement Secondary to Remdesivir Induced Bradycardia: A Case Report
Remdesivir is approved by the FDA for the treatment of hospitalized coronavirus disease 2019 (COVID-19) patients. It is known to be associated with transient bradycardia that resolves after discontinuation of the drug. We present a case of a 71-year-old male with a history of congestive heart failur...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710722/ https://www.ncbi.nlm.nih.gov/pubmed/36465748 http://dx.doi.org/10.7759/cureus.30923 |